Literature DB >> 31520704

Adenosine deaminase inhibition.

S Bagheri1, A A Saboury2, T Haertlé3.   

Abstract

Adenosine deaminase is a critical enzyme in purine metabolism that regulates intra and extracellular adenosine concentrations by converting it to inosine. Adenosine is an important purine that regulates numerous physiological functions by interacting with its receptors. Adenosine and consequently adenosine deaminase can have pro or anti-inflammatory effects on tissues depending on how much time has passed from the start of the injury. In addition, an increase in adenosine deaminase activity has been reported for various diseases and the significant effect of deaminase inhibition on the clinical course of different diseases has been reported. However, the use of inhibitors is limited to only a few medical indications. Data on the increase of adenosine deaminase activity in different diseases and the impact of its inhibition in various cases have been collected and are discussed in this review. Overall, the evidence shows that many studies have been done to introduce inhibitors, however, in vivo studies have been much less than in vitro, and often have not been expanded for clinical use.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cancer; Cancer staging; Diabetes; Disease grading; Purinergic signaling; Therapeutic strategies

Mesh:

Substances:

Year:  2019        PMID: 31520704     DOI: 10.1016/j.ijbiomac.2019.09.078

Source DB:  PubMed          Journal:  Int J Biol Macromol        ISSN: 0141-8130            Impact factor:   6.953


  12 in total

1.  Complete remission of aggressive T-cell LGL leukemia with pentostatin therapy: first case report.

Authors:  Margaret Li Krackeler; Catherine Broome; Catherine Lai
Journal:  Stem Cell Investig       Date:  2020-12-29

2.  A Metabolism-Related Gene Prognostic Index Bridging Metabolic Signatures and Antitumor Immune Cycling in Head and Neck Squamous Cell Carcinoma.

Authors:  Kunpeng Du; Jingwen Zou; Baiyao Wang; Chunshan Liu; Muhammad Khan; Tao Xie; Xiaoting Huang; Piao Shen; Yunhong Tian; Yawei Yuan
Journal:  Front Immunol       Date:  2022-06-30       Impact factor: 8.786

Review 3.  Expanding the repertoire of methanocarba nucleosides from purinergic signaling to diverse targets.

Authors:  Kenneth A Jacobson; Veronica Salmaso; R Rama Suresh; Dilip K Tosh
Journal:  RSC Med Chem       Date:  2021-07-13

4.  Synthesis of Sugar and Nucleoside Analogs and Evaluation of Their Anticancer and Analgesic Potentials.

Authors:  Fahad Hussain; Fahad Imtiaz Rahman; Poushali Saha; Atsushi Mikami; Takashi Osawa; Satoshi Obika; S M Abdur Rahman
Journal:  Molecules       Date:  2022-05-29       Impact factor: 4.927

5.  ELTD1 as a biomarker for multiple sclerosis: Pre-clinical molecular-targeted studies in a mouse experimental autoimmune encephalomyelitis model.

Authors:  Rheal A Towner; Nataliya Smith; Michelle Zalles; Sara Morris; MacKenzie Toliver; Debra Saunders; Megan Lerner; Gaurav Kumar; Robert C Axtell
Journal:  Mult Scler Relat Disord       Date:  2021-01-22       Impact factor: 4.339

6.  Primary Leptomeningeal B-cell Lymphoma in an Immunocompetent Adult: Case Report.

Authors:  Andrea Calderon-Castro; Leonardo Enciso; Rafael Tejada-Cabrera
Journal:  Cureus       Date:  2021-11-16

7.  Development of 18F-Labeled Radiotracers for PET Imaging of the Adenosine A2A Receptor: Synthesis, Radiolabeling and Preliminary Biological Evaluation.

Authors:  Thu Hang Lai; Susann Schröder; Magali Toussaint; Sladjana Dukić-Stefanović; Mathias Kranz; Friedrich-Alexander Ludwig; Steffen Fischer; Jörg Steinbach; Winnie Deuther-Conrad; Peter Brust; Rareş-Petru Moldovan
Journal:  Int J Mol Sci       Date:  2021-02-25       Impact factor: 5.923

8.  The association between serum adenosine deaminase levels and Graves' disease.

Authors:  Chun-Feng Lu; Wang-Shu Liu; Xiao-Qin Ge; Feng Xu; Jian-Bin Su; Xue-Qin Wang; Yan Wang
Journal:  Endocr Connect       Date:  2021-09-28       Impact factor: 3.335

Review 9.  Therapeutic Perspectives of Adenosine Deaminase Inhibition in Cardiovascular Diseases.

Authors:  Barbara Kutryb-Zajac; Paulina Mierzejewska; Ewa M Slominska; Ryszard T Smolenski
Journal:  Molecules       Date:  2020-10-12       Impact factor: 4.411

Review 10.  Adenosine-Metabolizing Enzymes, Adenosine Kinase and Adenosine Deaminase, in Cancer.

Authors:  Galina Zhulai; Eugenia Oleinik; Mikhail Shibaev; Kirill Ignatev
Journal:  Biomolecules       Date:  2022-03-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.